Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop. - sprookjes - yvandenbroek - TriplyDB

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.

http://www.wikidata.org/entity/Q38068392

about

Emerging technologies to measure neighborhood conditions in public health: implications for interventions and next steps Adaptive designs undertaken in clinical research: a review of registered clinical trials An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review Economic evaluations of personalized medicine: existing challenges and current developments Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project You may have worked on more adaptive designs than you think Dynamic Treatment Regimes Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials.The utility of Google Trends data to examine interest in cancer screening.Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials Designing clinical trials for dystonia.Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.Practical characteristics of adaptive design in phase 2 and 3 clinical trials.Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.Expand the toolkit!Selecting the right tool for the job.The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial.Perioperative THR-184 and AKI after Cardiac Surgery.Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.Sequential Multiple Assignment Randomized Trials: An Opportunity for Improved Design of Stroke Reperfusion Trials.Glomerular Diseases: Registries and Clinical Trials.Clinical trial data: ethical considerations in the face of technological advances

P2860

Q26747394-EB66BD7F-E9E0-47F0-9C5D-B840CE23F770 Q26753245-C64BB45A-3F95-4F8B-B8C3-63630AF215C2 Q26777085-5F9697AA-52FB-4D79-AF99-431C63BE0400 Q26797183-4FEED771-1637-4FCA-A759-A4262DA6E2E7 Q27332279-47CDBF5E-950A-4BC7-A17B-5B2606AC3AAC Q28085032-40411EC2-B314-48A2-8355-3B9713F69B58 Q30597725-7A4F5343-917B-468E-A841-519B049A9F43 Q30666196-968C7114-6A00-4DF7-B4C2-95B6E048CCD9 Q35657623-1CB1F725-4731-41B9-9594-7A7DE0A53FAD Q35689948-A30E8B0D-254C-4153-809A-D9ADB66E860A Q36402269-60D25D4F-7467-4C05-8CFD-40AE63D849E3 Q37506514-CE204305-BB46-414D-B304-BA90F02A9F3B Q38528288-CA6A55D1-9D56-423D-B7DE-4BAA027B68D0 Q38603746-632ADD3C-451E-47E0-A1CD-A635D7583027 Q38635940-1A2A809A-735A-481D-B68E-DA5861C9EEA4 Q38764294-5CB6FE59-E76C-47AE-9BFE-1C6E038938C6 Q40161554-E04C7B4F-75B9-4DE8-8B76-CC7A8CA2FDBD Q40161608-680C885E-792A-41BE-B7FF-EB061FC4C840 Q40330179-253EAD1B-E6B9-4C13-B6DE-885F9AE5182D Q46235968-CEA8F412-31B0-4918-83CE-8C5CF0D430CC Q47625359-D780AEA2-2803-4753-BF2E-E324DE70AECD Q48870458-033533A8-1818-43F9-8225-7FAB38CC9366 Q50281347-AF7F61B2-35AB-4CCA-90E1-1B080388A576 Q59153285-1E675F39-8EC7-4BFF-8F53-0BE3446E561B

P2860

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.

http://www.wikidata.org/entity/Q38068392

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Overview, hurdles, and future ...... tes of Health-funded workshop.

@en

type

label

Overview, hurdles, and future ...... tes of Health-funded workshop.

@en

prefLabel

Overview, hurdles, and future ...... tes of Health-funded workshop.

@en

P1433

Q38068392-5B298BEF-0085-4920-A73E-993089D21545

P1476

Q38068392-BE63A619-38A8-46C7-BA85-8CE1FD36C015

P2093

Q38068392-608BA92A-FFEF-4F15-A02F-B44BC6B8F0D7

Q38068392-6F62EA41-A389-4792-A8DB-E3CC2595CEB0

Q38068392-9A6993F9-B9B5-4EAD-8B35-8E160FEC285D

Q38068392-AF817475-0B4F-4C74-98F2-3CF9EFCEDF2B

Q38068392-D62F00EE-62B0-4318-973F-58D5B4A670AE

Q38068392-D82040F7-3DC3-4400-AB5E-C759B0220D86

P2860

Q38068392-119EDA1E-C212-4235-9C41-33F4437D3F1C

Q38068392-2A60F5A7-6B05-4728-83BE-DB555FA6E0C7

Q38068392-2AB2FCBD-2AA1-4BFB-B8CA-9104EA591159

Q38068392-2C759BF5-5E97-4567-8C1F-02AFDCD69F30

Q38068392-301613AB-19D7-48BC-B47D-6CEE77B0D57B

Q38068392-3E499E8B-D095-46D8-BBEF-A192F17002AD

Q38068392-495F58CA-5D28-4BA8-BB2F-483030355D3D

Q38068392-4E4F07C2-0F95-43C0-A519-BD0373EB38BF

Q38068392-55390FB8-8E1A-4C89-8106-CE0308FE68C3

Q38068392-59B27293-EF91-4407-B4C1-E20939A1408C

P304

Q38068392-13FC8C58-95AB-40F5-A22E-5F80EBDC3F04

P31

Q38068392-99203DC6-31B9-494D-94A7-1E88DEF6ADEE

P356

Q38068392-238336A4-DA00-46E9-926B-4BFF196C6B8B

P433

Q38068392-FB538F84-2051-4DBC-9384-6B109FCC791B

P478

Q38068392-6512F16B-D934-468C-B574-815593FE5508

P50

Q38068392-7A58BB89-8BB7-4447-803A-A15295C4B105

P577

Q38068392-2317897C-13BB-4DB0-928A-5D8521E32DEE

P698

Q38068392-C3745188-9BD3-404A-81F9-BB0AE0B9274C

P921

Q38068392-96DAE794-76BD-4587-8309-3030A48C34E3

P932

Q38068392-8DD0F0D8-5656-44A5-8EE8-262060EDF5FB

P356

1740774512461859

P1433

Clinical Trials

P1476

Overview, hurdles, and future ...... tes of Health-funded workshop.

@en

P2093

Bruce Levin

http://www.w3.org/2001/XMLSchema#string

Cate Timmerman

http://www.w3.org/2001/XMLSchema#string

Christina Clark

http://www.w3.org/2001/XMLSchema#string

Christopher S Coffey

http://www.w3.org/2001/XMLSchema#string

Peter Gilbert

http://www.w3.org/2001/XMLSchema#string

Sara Harris

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

On the independence of data monitoring committee in adaptive design clinical trials.

Adaptive clinical trials: progress and challenges.

Two-stage sample size re-estimation based on a nuisance parameter: a review.

An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project

The design of simulation studies in medical statistics.

Sample size recalculation in internal pilot study designs: a review.

Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop.

Adaptive design methods in clinical trials - a review.

P304

671-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774512461859

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23250942

http://www.w3.org/2001/XMLSchema#string

P921

P932

5570450

http://www.w3.org/2001/XMLSchema#string